成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 1404-93-9 Chemical Structure| 1404-93-9
Chemical Structure| 1404-93-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 1404-93-9

,{[proInfo.pro_purity]}

Vancomycin HCl is a HCl of vancomycin that is a narrow-spectrum glycopeptide antibacterial agent.

Synonyms: Vancomycin (hydrochloride); Vancomycin HCl; Lyphocin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Vancomycin HCl

CAS No. :1404-93-9
Formula : C66H76Cl3N9O24
M.W : 1485.71
SMILES Code : C[C@@H]1O[C@@](O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C(C=C(C=C3OC4=CC=C(C=C4Cl)[C@H]([C@H]5NC([C@@H](CC(C)C)NC)=O)O)[C@]6(NC([C@@H](NC5=O)CC(N)=O)=O)[H])OC7=C(C=C(C=C7)[C@H]([C@](C(N[C@](C(O)=O)(C8=CC(O)=CC(O)=C8C9=C(C=CC%10=C9)O)[H])=O)([H])NC([C@@]%10(NC6=O)[H])=O)O)Cl)CO)O)O)(C[C@](N)([C@@H]1O)C)[H].[H]Cl
Synonyms :
Vancomycin (hydrochloride); Vancomycin HCl; Lyphocin
MDL No. :MFCD03613611

Safety of Vancomycin HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of Vancomycin HCl

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1404-93-9 ]

[ 1404-93-9 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 80565-30-6 ]
  • [ 1404-93-9 ]
  • C79H82Cl3N9O24 [ No CAS ]
  • 2
  • [ 80565-30-6 ]
  • [ 1404-93-9 ]
  • N-4-(4’-chlorobiphenyl)methyl vancomycin [ No CAS ]
YieldReaction ConditionsOperation in experiment
10% The synthesis scheme for arriving at the glycopeptide derivative RV79 isdescribed below, and also provided at Figure 3. To a 40 mL vial equipped a stir bar was addedanhydrous DMF (20 mL) and DIPEA (0.20 mL). The resulting solution was heated to 65 ocon an incubated shaker and vancomycin·HCl (700 mg, 0.462 mmol) was added slowly inportions. Heating was continued until all ofvancomycin·HCl had dissolved (5-10 min). Thebeige colored solution was allowed to cool to room temperature at which point 4' -Chlorobiphenyl-4-carbaldehyde (0.1 g, 0.462 mmol) was added to the reaction mixture. The reactionmixture was allowed to stir overnight. MeOH (1.5 mL) and TFA (0.14 mL, 1.8 mmol) wereintroduced and stirring was further continued for at least 2 h. Borane tert-butylamine complex( 40 mg, 0.46 mmol) was added in portions and the reaction mixture was stirred at ambienttemperature for an additional2 h. After the reaction completed, the reaction mixture is purifiedusing reverse phase C 18 column chromatography (Phenomenex Luna 10 uM PREP C 18(2) 250x 21.2 mm column) using gradients of water and acetonitrile, each containing 0.1% ( v /v) ofTF A Fractions were evaluated using HPLC and then pertinent fractions containing RV79were pooled together for isolation of the product via lyophilization. The target compound, RV79 (81.2 mg, 0.05 mmol, 10% overall yield), was obtained as a white solid in >97% purity(by HPLC). The reaction scheme is shown at Figure 3
 

Related Products

Historical Records

Categories